Quality evidence · Certificate scope · Controlled project-document pathway

Pen injector quality documentation

Quality review should identify the certificate holder, issuing body, stated scope, validity and applicability to the selected project. REVADUO uses approved redacted public previews and provides applicable controlled evidence to qualified buyers through a project-specific document pathway.

pen injector quality documentationISO 13485 pen injectorMDSAP pen injector supplierdual chamber pen certificate
Scope matters more than a logo

A certificate image alone does not prove that every product, configuration or market is covered. Buyers should review the holder and exact scope.

Redacted manufacturing quality-system certificate preview

How to review manufacturing evidence

Certificate holder

Confirm whether the document belongs to REVADUO, a manufacturing partner or another supply-chain participant. The public site does not blur these roles.

Exact scope

Read the scope wording rather than relying on a badge. Component manufacturing, finished-device production and distribution are different statements.

Project applicability

Confirm whether the selected product, site, process and target market are covered by the evidence requested for the project.

Public versus controlled documents

Document levelTypical handling
Public webpageApproved redacted preview, certificate type, carefully stated scope and package-stated validity
Qualified project reviewApplicable certificate copies, drawings, dimensional information and available technical records
Confidential technical packageShared only after project qualification, authorization and confidentiality requirements are aligned
Sponsor validationDrug-device compatibility, formulation, filling and market-authorization evidence remain sponsor responsibilities

Claim boundary

The manufacturing evidence shown on the REVADUO website supports discussion of manufacturing partners and project pathways. It is not presented as proof that REVADUO directly holds every certificate or that every configuration is approved in every market.

  • No FDA approval claim.
  • No automatic product-clearance claim.
  • No public release of unredacted confidential evidence.

Request documents for a defined project

Share the selected product, market, buyer role and evidence needed for review.

Request a document review →
WhatsApp+86 131 9303 2415